... advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. 2024 Renal cell cancer Diabetes Metformin...

... to in the content or advertisements. 2023 Renal cell cancer Prognostic factors Non-clear cell Kidney tumor Renal cell carcinoma (RCC) accounts for approximately 4% of adult cancers and the rate of RCC has been increasing in all stages for the last two decades [ 1 ]. The clear cell RCC (ccRCC...

...A. Spek; B. Szabados; B. Ziegelmüller; C. Stief; M. D'Anastasi; M. Staehler Objectives: To evaluate the usage of different guidelines and to estimate the impact of changed recommendation in routine management, therapy and follow-up of patients with renal cell cancer (RCC). Methods: An anonymous...

...Stefan Zastrow; Anh Phuong; Immanuel von Bar; Vladimir Novotny; Oliver W. Hakenberg; Manfred P. Wirth Objectives: To investigate the controversially discussed relationship between tumor size and the occurrence of primary synchronous metastatic disease in renal cell cancer (RCC). Patients...

... or radical nephrectomy for kidney tumour between 2006 and 2010. Prevalence of cysts was evaluated retrospectively on a preoperative CT or MRI scan. Results: SRCs are more prevalent in patients with papillary renal cell cancer (RCC) than patients with clear cell RCC. All obese (BMI ≥30) patients in our study...

...Yun-Sok Ha; Yoshitomo Chihara; Hyung-Yoon Yoon; Yong-June Kim; Tae-Hwan Kim; Seung Hyo Woo; Seok-Joong Yun; Isaac Yi Kim; Yoshihiko Hirao; Wun-Jae Kim Objective: Although germline mutations of fumarate hydratase (FH) are a useful molecular marker of hereditary leiomyomatosis and renal cell cancer...

...(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Cytology Prognostic factors Renal cell cancer Urologia Internationalis Original Paper Urol Int 2011;86:466 469 DOI...

... Undergoing Systemic Therapy: Recommendations of a Multidisciplinary Consensus Meeting of the Association of Urological Oncology of the German Cancer Society Key Words Bladder cancer Computed tomography Germ cell tumors Magnetic resonance imaging PET-CT Prostate cancer Renal cell cancer Skeletal...

... with Sunitinib Malate Therapy Michael Staehler Nicolas Haseke Katja Zilinberg Thomas Stadler Christian G. Stief Department of Urology, University of Munich, Klinikum Grosshadern, Munich, Germany Key Words Renal cell cancer Sunitinib Cardiac failure Side effects Abstract A 74-year-old man with metastatic...

...M. Wirth Cytokines such as interferons, interleukin-2 and tumor necrosis factor have been widely tested in the treatment of advanced renal cell cancer. However, the rates of objective remissions (PR and CR) are disappointing and rarely exceed 20% overall. Until now, a definitive cure of a patient...

...T. Nishimura; Y. Terashima; T. Hattori; M. Satoh; Y. Kondo; G. Kimura; K. Yoshida; M. Akimoto We studied subsets and cytotoxicity of recombinant interleukin-2 (rIL-2)-expanded tumor-infiltrating lymphocytes (TIL) from renal cell cancer (RCC) patients. TIL were successfully expanded in 13 of 14 RCC...

...Hartmut E.H. Wegner; Gudrun Bornhöft; Klaus-Peter Dieckmann Three patients (1 man, 81 years old; 2 women, 56 and 61 years old) had renal cell cancer and transitional cell cancer in the same kidney, and another patient (female, 77 years old) had renal cell cancer and transitional cell cancer...

...Yoshihiko Tomit; Tsutomu Nishiyama; Michio Fujiwara; Shotaro Sato In order to determine whether tumor-infiltrating mononuclear cells (TIM) of renal cell cancer (RCC) is suitable for adoptive immunotherapy, their number and characteristics were examined immunohistologically. TIM consisted of T cells...

..., Eberhard Karls University Tuebingen, Tuebingen, and bDepartment of Urology, University of Ulm, Ulm, Germany Key Words Renal cell cancer Cathepsin D Enzyme immunoassay mass. Further prospective multicenter studies might shed more light on the value of Cath D in the diagnostics of RCC. Copyright © 2007 S...

..., instructions or products referred to in the content or advertisements. Renal cell cancer p53 mutations Prognosis Original Paper Urol Int 2001;66:78 83 Received: December 10, 1999 Accepted after revision: September 15, 2000 p53 Mutations and Other Prognostic Factors of Renal Cell Carcinoma Cengiz...

.... This study shows the long-term results obtained in 92 metastatic renal cell cancer (RCC) patients with low-dose subcutaneous IL-2, which was given at 3 million IU twice/day for 5 days/week for 6 consecutive weeks. In nonprogressing patients, a second cycle was planned after a 21-day rest period, followed...